Essential Regulatory Requirements for Laboratory Weighing

Weighing is a crucial step in analytical procedures, making lab scales indispensable in QC labs. Explore this page to understand how the essential requirements for lab balances are described in different chapters of international pharmacopeias like USP <1251>, USP <41>, Eur.Ph. 2.1.7, JP 9.62, FDA requirements for electronic records and data integrity as described in 21 CFR part 11 and general guidelines like the calibration guide no. 18 (EURAMET cg18) published by the association of European metrology institutes.

Learn more about the key requirements for electronic balances in QC labs, focusing on good practices, compliance with international regulations, minimum sample weight, and data integrity.

Introducing the Cubis® II for Connectivity & Compliance

Cubis® II by Sartorius ensures precise results, regulatory compliance, and seamless connectivity with modern IT environments.

Enhance your laboratory's efficiency and data integrity with Cubis® II's intelligent functions, comprehensive audit trails, and customizable workflows, designed to meet the demands of Lab 4.0.

icon-cubis-II-configurator

Cubis® II Configurator: Your Custom Balance in 4 Easy Steps

Configure Now

Regulatory Landscape for Compliant Lab Weighing

United States Pharmacopeia <1251> - Weighing on an Analytical Balance

USP general chapter <1251> offers best practices for laboratory weighing, including selecting the right balance for accuracy, proper placement and installation, calibration and verification, routine testing and maintenance, correct weighing techniques, and documentation and traceability of procedures.

Download the Infographic for an optimal use of your lab balances in Pharma industry

United States Pharmacopeia <41> - Balances

USP general chapter <41> outlines stringent requirements for laboratory balances, focusing on accurate weighing, calibration, and adherence to standards for repeatability and accuracy, including the concept of the smallest net weight. This chapter ensures that balances used in pharmaceutical applications meet precise criteria to maintain the integrity of measurements.

Download our detailed USP <41> generic operating procedure.

European Pharmacopeia General Chapter 2.1.7 – Balances for Analytical Purposes

EP 2.1.7 provides comprehensive guidelines for the use and maintenance of analytical balances, covering principles of mass determination, installation considerations, and the use of appropriate weighing vessels. It emphasizes the importance of calibration, repeatability, sensitivity, and adherence to the minimum weight requirement in performance checks.

Download a detailed EP 2.1.7 compliance guide

EURAMET Calibration Guide No. 18 – Guidelines on the calibration of Non-Automatic Weighing Instruments

The EURAMET cg-18 guide details the calibration of non-automatic weighing instruments to ensure consistent and recognized results across laboratories. It includes calibration elements, test loads, measurement methods, uncertainty, and certificate preparation, with appendices on air buoyancy, convection effects, and minimum weight. Calibration is done over to maintain high standards in mass measurement.

Download this white paper to learn about the calibration guideline, measurements carried out as part of the calibration process and Sartorius specifications

Japanese Pharmacopeia Chapter 9.62 - Measuring Instruments, Appliances

Chapter 9.62 of the Japanese Pharmacopoeia has been extensively revised and published in June 2024to include detailed requirements for the calibration, repeatability, and accuracy of balances, emphasizing the importance of the smallest net weight. It mandates that balances be calibrated to ensure traceability to the SI and that repeatability checks confirm the minimum weight is smaller than the smallest net weight. Additionally, the chapter requires periodic accuracy checks to ensure sensitivity errors are within acceptable limits.

Download FAQ

Uniformity of dosage unit described in EP 2.9.40 - USP <905> - JP 6.02 and harmonized by ICH guidance Q4B annex 6

EP 2.9.40, USP <905>, and JP 6.02 describe the test for drug content uniformity in dosage units such as tablets and capsules in pharmaceutical or nutraceutical quality control. This test ensures that each individual unit of a drug product contains the intended amount of active ingredient within an acceptable range. Accurate weighing is crucial in these procedures, as it directly impacts the assessment of dosage uniformity, including criteria for acceptance based on statistical sampling and analysis.

Download the application highlight to learn how weight testing can be easily performed using the Cubis® II MCA balance and QApp tablet check.

Residue of ignition described in EP 2.4.14 - USP <281> - JP 2.44 and harmonized by ICH guidance Q4B annex 1

The residue on ignition - or sulfated ash - test described in EP 2.4.14, USP <281>, and JP 2.44 determines the amount of residual substance remaining after a sample is ignited, which is crucial for assessing the purity and quality of pharmaceutical substances. Accurate weighing by difference is essential in this procedure, as it is directly involved in the determination of the residue amount.

Download this informative application highlight to learn more about the role Cubis® II balances streamline the test procedure.

Loss on drying described in USP <731> - EP 2.2.32 - JP 2.41

The loss on drying (LOD) test, described in USP <731>, EP 2.2.32, and JP 2.41 measures the amount of volatile matter, such as water, in a sample. This test is crucial for determining the moisture content of pharmaceutical substances, which can affect their stability, efficacy, and shelf life. Accurate differential weighing is essential as it directly impacts the precise determination of the moisture content.

In the Cubis® II application, administrators can select USP or PhEur test procedures and choose the sample type—tablet or capsule. This determines how the software evaluates pass or fail based on weight differences. Download the application note to learn more.

Electronic records and data integrity as described in 21CFR Part 11, EU Annex 11 or ALCOA principle

21 CFR Part 11, EU Annex 11, and the ALCOA principles are essential for ensuring compliance in electronic data management within the pharmaceutical industry. These regulations outline Good Manufacturing Practice (GMP) protocols, including the use of electronic signatures, data integrity, and system validation, to ensure that electronic records are trustworthy and reliable.

Download the infographic for an overview of key terms and definitions, points of compliance, and ways to achieve quality control and data integrity.

Certified and accredited services for lab weighing instruments

Sartorius Services ensure lab balances meet GLP/GMP standards, providing audit security and comprehensive documentation. Our risk-based IQ/OQ qualification ensures compliance and peace of mind. Regular maintenance contracts enhance process safety, extend instrument life, and ensure reliable results. Calibration services guarantee accuracy, regulatory compliance, and traceability, with certificates meeting ISO/IEC 17025, USP, and European Pharmacopeia standards.

Find the lab weighing service you need.

Ensuring Data Integrity: Connected Solutions

Data Integrity is a necessity in scientific research and pharmaceutical manufacturing. It is essential for reliable results, ensures compliance, product quality, and patient safety. In order to stay compliant, modern lab equipment is designed to simplify data integrity compliance by automation. Explore this infographic to understand the importance of data integrity, the FDA’s focus on data integrity violations, and ultimately Sartorius connected solutions that help ensure compliance.

Get the Infographic Now

Audit Preparedness with Cubis® II Balances

Many analytical techniques involve weighing steps, where errors can occur. These mistakes can have significant and cumulative effects, potentially leading to invalidation of release tests, cross-contamination, or high analytical uncertainties. Recognizing the importance of accurate weighing, pharmacopoeias provide guidance on planning, verification, and protocol.

This guide helps you understand how the Cubis® II balances secure your daily weighing reliability and back you up for internal or external audits.

Access the Audit Preparedness with Cubis® II Balances eBook

Cubis® II - Pharma Compliant by Design

Get the White Paper

Pharma Compliant Weighing Resources

Lab Balance Powder Weighing Boat Application Image Close
Webinar

Weighing Masterclass: Understanding Measurement Uncertainty 

Weighing and Sample Management Solutions for Pharmaceutical Quality Control

Yellow rocket taking off from a laptop, startup and technology concept, black background.
Webinar

You're Now Connected: Prepare Your Lab for the Future

This webinar will explore the crucial roles of data integrity and laboratory connectivity in the lab.

Challenges In Testing of Dosing Accuracy According to IEC
Application Note

Dosing Accuracy Testing According to IEC 60601-2-24 And AAMI TIR-101

Discover the precision of Sartorius Cubis® II balances in ensuring accurate dosing rates for infusion pumps

Inspecting Cubis instrument
White Paper

Best Practices Guide: Lab Weighing

Discover practical guidance on weighing in the lab, including calibration, accreditation, legal metrology and correct weighing.

Technical Note

Lab Weighing: Generic Operating Procedures for Routine Testing

Our series of Generic Operating Procedures provides valuable information about routine testing of lab balances. Discover more!

eBook: Cubis® II MCA 21 CFR Part 11 Compliance Checklist
eBook

Cubis® II MCA 21 CFR Part 11 Compliance Checklist

Detailed insights into FDA’s 21 CFR Part 11 standards for electronic records and electronic signatures.

Use of Laboratory Balances in the Pharmaceutical Industry cover
White Paper

Use of Laboratory Balances in the Pharmaceutical Industry

Our white paper summarizes USP Chapters <41> and <1251> and the new European Pharmacopoeia Chapter 2.1.7.

Application Note

Formulation QApps Using a Database With Cubis®II

This is the use case description for the QApps Formulation in multiple vessels and Formulation in single vessel.

Application Note

Net Weight Control of Prepackaged Goods and Drugs

Learn more about Sartorius software packages for Cubis® II balances and how they can help you meet quality and safety regulations.

Measurement Inaccuracy of Rapid Moisture Analyzers as a Function of Sample Quantity
Application Note

Measurement Inaccuracy of Rapid Moisture Analyzers

Control of moisture content helps to prevent microbial growth and ensures that bulk powders flow properly.

Discover How Omnis and Cubis II Can Help You With Your Karl Fisher Titration Method!

Seamless Integration of Cubis® II into Metrohm OMNIS Analytical Software System

Discover OMNIS

View Webinar


Request a Quote, Demo, or More Information

What other areas are you interested in? (select all that apply)

Get in Touch With an Expert